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High-throughput crystallography has reached a level of automation where
complete computer-assisted robotic crystallization pipelines are capable of
cocktail preparation, crystallization plate setup, and inspection and interpreta-
tion of results. While mounting of crystal pins, data collection and structure
solution are highly automated, crystal harvesting and cryocooling remain
formidable challenges towards full automation. To address the ﬁnal frontier in
achieving fully automated high-throughput crystallography, the prototype of an
anthropomorphic six-axis universal micromanipulation robot (UMR) has been
designed and tested; this UMR is capable of operator-assisted harvesting and
cryoquenching of protein crystals as small as 10 mm from a variety of 96-well
plates. The UMR is equipped with a versatile tool exchanger providing full
operational ﬂexibility. Trypsin crystals harvested and cryoquenched using the
UMR have yielded a 1.5 A ˚ structure demonstrating the feasibility of robotic
protein crystal harvesting.
1. Introduction
Structure-based methods are progressively gaining impor-
tance in drug lead discovery and design, and the number of
therapeutic drugs developed with major contributions from
structure-guided methods is rapidly increasing (Congreve et
al., 2006). In particular, automated high-throughput drug
target crystallography and associated enabling technologies
have contributed signiﬁcantly towards rational structure-
based drug design. Computer-assisted robotic crystallization
pipelines are capable of cocktail preparation, crystallization
plate setup, and inspection and interpretation of results. The
mounting of crystal pins, data collection and structure solution
are also highly automated (Karain et al., 2002; Pﬂugrath, 2004;
Snell et al., 2004; Beteva et al., 2006), and more and more
beamlines are being equipped with pin mounting robotics
(http://smb.slac.stanford.edu/robosync/). Numerous pharma-
ceutical companies have thus implemented powerful crystal-
lography pipelines, capable of screening numerous drug
targets and receptor-ligand complexes per day (Blundell et al.,
2002; Hosﬁeld et al., 2003; Congreve et al., 2006).
In contrast to the screening-related liquid- and plate-
handling tasks, as well as the manipulation of crystals once
they are cryoquenched, the actual harvesting of the crystals is
still performed with manual tools under a microscope. The
effect of this break in the automation pipeline is manifold: in
addition to the creation of a process bottleneck, particularly in
pharmaceutical receptor-ligand screening and crystallographic
fragment screening (Burley, 2004), the critical harvesting
operations occur late in the process and are a major source of
loss of valuable crystals. Avoiding expensive late-stage failure
during harvesting is a major step towards increased process
efﬁciency and cost reduction (Rupp, 2003). Moreover, the
physics of cryocooling (Garman, 1999; Nave & Garman, 2005)
are still one of the least well understood areas in protein
crystallography. To a large degree, the difﬁculty in exploring
cryoprocedures is rooted in the poor reproducibility of skill-
dependent manual harvesting. Consistent robotic or robot-
assisted harvesting, combined with novel hyperquenching
techniques (Warkentin et al., 2006), will thus impact our ability
to systematically optimize cryotechniques for faster, more
reliable crystal cooling.
In a ﬁrst stage towards fully automated high-throughput
crystallography, we have designed and tested an anthropo-
morphic six-axis universal micromanipulation robot (UMR)
capable of reliably harvesting and cryoquenching protein
crystals as small as 10 mm from a variety of 96-well plates. The
UMR arm is equipped with a versatile tool exchanger. Tape
cutters, harvesting pins with MiTeGen MicroLoops (Thorne et
al., 2003), cryoliquid exchange and custom tools provide
additional operational ﬂexibility. The current user interface is
a simple game-style keyboard layout allowing intuitive manual
control. Semi-automated process steps such as tool location,
loop approach to crystals, as well as fully automated tape
cutting and quenching have been implemented in the proto-
type. Integrated machine vision and object tracking are indevelopment to achieve minimally supervised automated
crystal harvesting.
In a ﬁrst demonstration of operator-assisted robotic
operation, we have harvested and cryoquenched a series
of 32 different crystals (lysozyme, concanavalin A, glucose
isomerase and bovine trypsin) from 96-well sitting-drop plates
(1 ml drops) used in automated crystallization pipelines as well
as from 24-well CrysChem plates (2 + 2 ml drops) used for
manual sitting-drop setup. A movie showing operator-assisted
harvest of a  80 mm lysozyme crystal from a 96-well plate is
available from http://www.ruppweb.org/cryscam/lysocapture.wmv.
A bovine trypsin crystal harvested using the UMR yielded
1.50 A ˚ -resolution data and a well reﬁned structure with an R
value of 0.153 and an Rfree of 0.176. To our knowledge, this is
the ﬁrst structure from a crystal that has not been directly
manipulated by human operators during harvesting and
quenching, and it seems to be among the highest resolution
trypsin structures reﬁned from in-house data.
Contributing to the high resolution of our trypsin structure
is probably the fact that the crystals were grown under
conditions that included additives believed to assist in forming
crystal contacts (McPherson & Cudney, 2006). The backbone
trace of a fragment presumed to be a salmon protamine
peptide is visible in weak electron density intercalated
between three symmetry-related trypsin molecules.
2. The universal mounting robot
For a robot to harvest protein crystals successfully, it is
essential that it be able to mimic the subtle dexterous motions
of a human technician. Furthermore, the robot needs to have
motion resolutions at least one order of magnitude ﬁner than
the diameter of the smallest crystals it will be required to
handle. We determined that a six-axis robot with articulated
arm geometry was the best choice for this application.
Commercial robots are generally not required to operate in
the micrometer realm, so the need for special modiﬁcations to
this robot’s actuators, encoders and mechanical linkages was
anticipated. As outlined above, we sought to endow the
system with a broad range of operational capabilities by
equipping it with an automated tool exchange capability and
providing access to a library of task-speciﬁc end effectors. A
video camera with motorized zoom lens provided the system’s
operator with a high-resolution image of the work volume
within a well. The goal was to create a rugged, in the ﬁrst
development phase tele-operated, robotic work cell capable of
efﬁciently performing the full range of tasks associated with
crystal harvesting.
2.1. Concept and design
The design team chose the Sta ¨ubli RX60 (Fig. 1) as the core
robotic component for this application. This Swiss-made robot
has been used successfully in a number of very high-precision
applications and was deemed to offer the best combination of
payload, reach and resolution. Other than minor modiﬁcations
made to the transmission linkages at the factory, this was an
‘off-the-shelf’ robot. Initial testing of the robot demonstrated
its ability to translate the tip of a standard sample pin with a
resolution consistent with the needs of crystal harvesting.
Consequently, no further modiﬁcations were made to the
robot.
Special end effectors were designed to provide for plate
handling, tape cutting and crystal harvesting (Fig. 2). In each
instance, these designs simply adapted existing manual process
tools and provided a means for precisely aligning these tools
relative to the robot. Each end effector incorporated kine-
matic mounting features allowing it to be accurately registered
in a storage library at the edge of the work cell. Testing
conﬁrmed the system’s ability to reliably perform all basic
material handling tasks.
Initial tests of the system’s ability to harvest crystals were
performed using relatively large ( 200 mm) lysozyme crystals
grown in a sitting-drop conﬁguration. With some practice, an
operator was able to capture these crystals successfully via the
robot’s keyboard-driven user interface. Tests were performed
using both standard nylon loops provided by Hampton
Research and etched Kapton loops manufactured by
MiTeGen (Thorne et al., 2003). While both types of loops
worked, the Kapton loops were easier to manipulate relative
to the crystal and allowed the capture sequence to be
performed more quickly. In subsequent tests, only Kapton
loops were used.
The next sequence of tests veriﬁed the system’s ability to
capture crystals within a variety of sitting-drop wells. As with
the hanging-drop experiments, some practice was needed
before an operator was able to maneuver the tip of the
harvesting loop efﬁciently within the geometry of a well.
However,once these maneuvers were perfected, tele-operated
capture was rapid and reliable (Fig. 3). With this success,
progressively smaller lysozyme crystals were harvested,
culminating in the capture of crystals only 10 mm in diameter.
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Figure 1
The UMR prototype. The core of the system is a Sta ¨ubli RX 60
anthropomorphic six-axis robot, equipped with a versatile pneumatically
operated tool exchanger, giving the robotic arm access to a wide range of
harvesting loops, microtools and liquid exchange capability.The feasibility of robotic crystal cleaving and other micro-
surgical operations were also veriﬁed.
2.2. Operational tests and system integration
Following successful demonstration of the robot’s ability to
perform individual process tasks, system-level tests of the
UMR were performed. The goal of these tests was to
demonstrate the ability of the UMR to seamlessly perform the
sequence of tasks required to completely open the bottleneck
associated with the crystal harvesting process. Microtiter
plates enter the system through an input port, where the robot
accepts the tray and presents it to the imaging module.
Magniﬁed images of each of the plate’s wells are acquired and
displayed to the system operator. Once the operator identiﬁes
those wells that hold usable crystals, the robot precisely cuts
through the tape, acquires the appropriately sized harvesting
loop and positions the tip of the loop in the center of the well.
The operator then takes direct control of the robot and
performs the necessary harvesting and cryoprotecting opera-
tions. Finally, the operator returns control back to the robot
and the robot automatically cryoquenches the crystal (Fig. 4).
During a series of tests with numerous crystals grown in
varying plates under different conditions, the feasibility of a
tele-operated UMR was established. Ultimately, a crystal
structure of trypsin complexed with benzamidine was reﬁned
at 1.5 A ˚ from data collected from a robotically harvested and
cryoquenched crystal.
2.3. Future developments
Following the success of the tele-operated harvesting, we
will now attempt to expand the functionality of the UMR
concept and establish its ability to perform the full range of
crystal harvesting tasks autonomously. Reﬁnement of the tele-
operated prototype, veriﬁcation of an appropriately resolved
sensory capability (machine vision in this case) and successful
conversion of operator-directed robot commands into well
research papers
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Figure 2
Detailed view of the tool exchanger and tool storage (left panel), and the plate manipulator tool attached to the tool exchanger (right panel).
Figure 3
Tool exchanger with harvesting wand carrying a magnetic base Hampton Research CrystalCap pin with Kapton cryo-loop (left panel). A harvested
30 mm lysozyme crystal dyed with methylene blue in the MiTeGen harvesting loop is shown in the right panel.deﬁned automated motion routines are the three crucial
elements needed to create a self-directed system; we plan to
investigate each of these elements systematically. Next, a fully
realized UMR with expanded functional capabilities will be
built and tested. The primary goal of this phase of the project
will be to unite the precision robotics already developed with
reﬁned machine vision guidance in order to removethe human
operator entirely from the crystal harvesting process. Higher-
order micromanipulation devices will also be investigated in
an effort to lower the system’s crystal capture threshold below
1 mm, which will allow harvesting of even the smallest crystals
and added precision in micromanipulation procedures, such as
dissecting macroscopically twinned or inter-grown crystals.
While crystals smaller than 10 mm are of limited value for
routine diffraction (generally requiring data collection on
specialized microfocusing beamlines), microcrystals may still
be useful for seeding operations. Fluid handling will be
incorporated into the UMR allowing the system to apply
cryoprotectants to mature crystals and to create protein-ligand
complexes. Full support of hyperquenching cryotechniques
(Warkentin et al., 2006) will signiﬁcantly extend the conditions
under which crystals can be successfully cryomounted. The
system’s capability to perform necessary ‘pedestrian’ functions
such as plate handling, plate positioning, tape piercing and
resealing will also be reﬁned.
One of the most relevant issues for harvesting from small
drops (drops in the 100 + 100 ml range are routinely used in
robotic setup) is the time needed for harvesting. Tool
exchange is very fast (3–5 s) and movement of tools into close
proximity of crystals can be performed with high motor speed
settings, which will allow the reduction of open well time
substantially, while at the same time delicate movements
involving crystals can be preformed with great accuracy and
consistency. Tool handling is generally very fast and simple for
the UMR robot. As a typical example, the change of the
harvesting loop from one hand to the other, required by a
change in approach position to the well, is difﬁcult even for an
ambidextrous operator. For the UMR, only a trivial tool
rotation is involved. We think that optimization and automa-
tion of numerous steps using the UMR will ultimately mini-
mize harvest times and thus drastically reduce the risk of
dried-up crystallization drops before the operation can be
completed.
3. Structure of robotically harvested trypsin–
benzamidine complex
3.1. Crystallization
Bovine trypsin (60 mg, Sigma Chemicals) was mixed with
benzamidine (5 mg, Sigma Chemicals) and dissolved in 1 ml of
0.1 M HEPES buffer at pH 7.0 containing 3 mM CaCl2.T h e
protein–benzamidine complex was then crystallized by sitting-
drop vapor diffusion (McPherson & Cudney, 2006) in
Cryschem plastic plates (Hampton Research, Aliso Viejo,
CA). The sample drops were composed of 2 ml of the protein–
benzamidine stock and 2 ml of 15% PEG 3350 in 0.1 M
HEPES pH 7.0, also containing 10 mg ml
 1 of salmon sperm
protamine (Sigma Chemicals). The sample yielded ortho-
rhombic prismatic crystals after about one week at 295 K.
3.2. Robotic harvesting and cryocooling
The sitting-drop plate containing trypsin crystals was loaded
into the UMR and positioned relative to the imaging optics.
Candidate crystals were identiﬁed by the system’s operator
and robotically harvested as described in x2 using an appro-
priately sized Kapton loop.Immediately followingcapture, the
crystals were quenched in liquid nitrogen and inserted into a
cryostorage puck as depicted in Fig. 4.
3.3. Data collection
Hampton Research CrystalCap pins containing the cryo-
protected robotically harvested crystals in MiteGen Kapton
loops (Thorne et al., 2003) were directly mounted out of liquid-
nitrogen storage pucks using cryo-tongs. Diffraction data of
the orthorhombic P212121 crystals were collected in anom-
alous data collection strategy at 100 K with a Platinum
135 CCD
detector using Cu K radiation from a Bruker MICROSTAR-
H rotating-anode generator operating at 2.7 kW. Intensities
were integrated and scaled using the PROTEUM software
suite (Bruker, 2004). Data collection statistics are summarized
in Table 1.
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Figure 4
Automated cryoquenching of a crystal in liquid nitrogen. The sample
magazine used during the tests was a simpliﬁed version of the ‘cryo-
pucks’ currently in use at a number of synchrotron light sources. Because
of the system’s inherent ﬂexibility, the UMR can be conﬁgured for
compatibility with any type of storage magazine currently in use.3.4. Structure solution and refinement
The processed diffraction data in SCALEPACK (Otwi-
nowski & Minor, 1997) format and the starting model (PDB
code 1v2l) were submitted to the Shake & wARP (SNW)
package (Reddy et al., 2003) for molecular replacement, rigid-
body reﬁnement and generation of multiple-averaged bias
minimized SNW maps. Manual adjustment and rebuilding in
Xtalview (McRee, 1999) and Coot (Emsley & Cowtan, 2004)
was followed by maximum-likelihood reﬁnement in
REFMAC5 (Murshudov et al., 1997). After building of water
structure and repeated bias removal using SNW, further
features in the electron density could be built. We placed the
inhibiting benzamidine in its unambiguous electron density
and built phenol molecules, presumably originating from the
protamine preparation, in two alternate conformations in
corresponding density. At this stage, real-space correlation of
the trypsin model was excellent (Fig. 2), Rfree was 18.3, and
weak but in large parts contiguous electron density could be
detected between neighboring molecules in both SNW and
mFo–Dfc maps.
The residual density was approximated as the backbone
trace of a peptide, probably resulting from the salmon
protamine extract and built as polyglycine. At several C
positions, adjacent C density was present, but no sequence
assignment was possible. Although Rfreedropped to 0.176 after
ﬁnal reﬁnement (R = 0.153), the exact conformation and
nature of the peptide remains undetermined. A water mole-
cule in an octahedral environment showed positive difference
density and reﬁned to low B values, suggesting a second metal
binding site in addition to the constitutive Ca
2+ ion in trypsin.
A phased anomalous difference map showed a weak peak, and
based on bond distances a sodium ion was placed in the
density as a probable cation, although partial occupation by
other cations cannot be excluded. There were no indications
of anisotropy in the electron density maps, and neither TLS
reﬁnement nor partial introduction of anisotropic B factors
led to signiﬁcant improvements in Rfree. Reﬁnement statistics,
coordinate r.m.s.d. and geometry statistics are compiled in
Table 1. In a ﬁnal polishing step, all Asn, Gln and His side-
chain conformations were checked for chemical plausibility
(Weichenberger & Sippl, 2006), and close distance deviations
(bumps) of more than 0.2 A ˚ from WHATCHECK targets
were corrected (Hoft et al., 1996). Coordinates and structure
factors (code 2j9n) have been deposited with the Protein Data
Bank and validated during deposition at EBI-MSD via
autodep and the EDS (Kleywegt et al., 2004) service.
3.5. Packing analysis of trypsin
Trypsin is a hardy perennial of protein crystallography,
and atomic resolution structures of trypsin, particularly of
Fusarium oxysporum (Schmidt et al., 2003), have been used to
analyze details of the reaction pathway and molecular move-
ments in the enzyme. Crystals of benzamidine-complexed
trypsin (Kd ’ 20 mM) served as a model in the recently
developed radiation-induced phasing (RIP) technique (Nanao
et al., 2005). Nearly 260 structures of trypsin from various
species, complexed with other inhibitors, and in substrate
complexes have been determined (compiled in the REMARK
900 section of PDB entry 2j9n).
Trypsin is a member of the ubiquitous family of serine
proteases. It is secreted by the pancreas as the proenzyme
trypsinogen and converted to the active form in the small
intestine by enteropeptidase. As an endo-petidase, active
trypsin cleaves substrates at the C-terminal of Arg and Lys,
and catalyzes the cleavage and activation of additional tryp-
sinogen and other pancreatic proenzymes important to
protein digestion. The calytic triade in the binding pocket
consists of Ser, His and Asp (residues 192, 55 and 99 in our
model).
3.5.1. Binding site environment. Comparison with a
representative atomic resolution structure (in the ortho-
rhombic P212121 crystal form with cell constants of  54, 57
and 66 A ˚ ) of bovine trypsin in complex with the competitive
inhibitor benzamidine (PDB entry 1j8a; Cuesta-Seijo &
Garcia-Granda, 2002) shows excellent overall agreement
(superposition with 0.23 A ˚ overall r.m.s.d.). The binding site
contains the benzamidine inhibitor, fully occupied and in a
position practically identical to that in other high-resolution
research papers
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Table 1
Data collection and reﬁnement statistics.
Data collection
Space group P212121
Wavelength (A ˚ ) 1.54178
a (A ˚ ) 53.92
b (A ˚ ) 56.70
c (A ˚ ) 66.05
Resolution (A ˚ ) 25.09–1.50 (1.57–1.50)





Number of molecules in a.u. 1
Vm (Matthews coefﬁcient) 2.03
% Solvent 39.1
Reﬁnement
Free R value†, random, 5% 0.176 (0.281)
R value† 0.156 (0.198)
r.m.s.d. bond length (A ˚ )‡ 0.012
r.m.s.d. bond angle ( )‡ 1.394
Overall coordinate error (A ˚ )§ 0.068
RSCC (Shake & wARP)} 0.96
RSCC (REFMAC5)†† 0.97
EDS map Rvalue‡‡ 0.177
Ramachandran appearance§§ nonglycine
Most favored region (residues, %) 164 (87.2)
Additional allowed (residues, %) 24 (12.8)
Generously allowed (residues, %) 0
Disallowed (residues, %) 0
† Values in parentheses for the highest resolution bin in reﬁnement (1.54–1.50
A ˚ ). ‡ Deviations from restraint targets (Engh & Huber, 1991). § Estimated standard
uncertainty, diffraction precision index (DPI) based on Rfree (Cruickshank,
1999). } Real-space correlation coefﬁcient, Fc map against averaged and weighted
Shake & wARP map. †† Real-space correlation coefﬁcient, Fo map against Fc map, as
reported by REFMAC5. ‡‡ Returned by EDS validation server (Kleywegt et al., 2004)
during deposition via autodep (EBI-MSD). §§ Regions as deﬁned in PROCHECK
(Laskowski et al., 1993).structures (Fig. 5). A number of water molecules in the
binding site are also conserved, amongst those the W1 water
molecule (next to the histidine of the catalytic triade), shown
to act as nucleophile in the cleavage reaction (Schmidt et al.,
2003). In the P212121 crystal form typical for trypsin inhibited
with the arginine analogue benzamidine, the position of the
natural peptide substrates is occupied by a symmetry-related
molecule (Fig. 6).
3.5.2. Intercalating density. Of particular interest in our
structure are the nature and location of the intermolecular
entities connecting three neighboring molecules in the P212121
structure. Bias-minimized SNW electron density maps (Reddy
et al., 2003) as well as maximum-likelihood/SigmaA mfo–Dfc
(DELFWT) maps created with REFMAC5 (Murshudov et al.,
1997) show distinct density fragments, which at lower contour
levels of 0.7–0.5 became contiguous over a large distance
equivalent to more than 20 amino acid residues. Given that the
main additive in the crystallization cocktail was a salmon
protamine extract (SPE), there are several possibilities of
which macromolecular entities could be located between the
molecules. SPE contains various highly cationic peptides,
generally basic and arginine rich, as well as other potential
components such as polyamines of the spermidine/spermine
family. The fact that the electron density, despite the high
resolution of the remaining structure, did not show side-chain
features distinct enough to allow a clear assignment of resi-
dues and directionality seems to indicate that a mixture of
peptides in multiple conformations, possibly also polyamines
in the region where no side chains can be accommodated, are
linking the molecules.
There is in fact precedence for intermolecular contact
mediation of protamine peptides in crystal structures. Strik-
ingly similar fragments have been located in crystal interfaces
of insulin in drug formulations
containing the protamine clupeine
(Balschmidt et al., 1991). Interestingly,
in this insulin structure, a phenol deri-
vative (m-cresol) has also been found to
mediate crystal contacts, and phenol has
been used to stabilize other insulins
(Derewenda et al., 1989). In the absence
of a clear assignment, we have modeled
our density as a three- and a 16-residue
polyglycine backbone (possibly led by
an N-terminal lysine residue) as a
placeholder for what is probably a
mixture of intercalated peptides and
other SPE components. Unassigned
density that could correspond to the
guanidyl groups of arginine in the vici-
nity of acidic residues and hydrogen-
bond acceptors has been observed, but
ordered side chains could not be built,
probably as a consequence of the
substantial entropic loss that would
accompany rigid arginine conforma-
tions. The averaged B factors ( 70 A ˚ 2)
of the peptides are accordingly higher than those of surface-
exposed trypsin residues ( 16 A ˚ 2), indicating partial occu-
pation and/or disorder. To emphasize the tentative assign-
ment, we used the residue name UNK for these peptides in the
PDB ﬁle.
Despite the weak density, our intercalated model trace
displays features that are compatible with an arginine- and
lysine-rich basic peptide; as shown in Fig. 7, the peptide
density snakes though the interface between the molecules so
that its basic side chains would indeed make contacts with
negatively charged patches on the molecules, whereas back-
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Figure 5
Real-space correlation coefﬁcients against a bias-minimized SNW map (black) and B factors (blue)
for the ﬁnal model of trypsin 2j9n, demonstrating the quality of the trypsin model obtained from the
robotically harvested crystals. Inserts shows SNW omit electron density of thebenzamidine inhibitor
(left) and the phased anomalous difference map of the disulﬁde bond Cys40—Cys56. Density ﬁgures
were generated using Xﬁt (McRee, 1999) and Raster3d (Merritt & Bacon, 1997).
Figure 6
Packing of trypsin molecules with intercalating peptide. Two symmetry-
related molecules are shown in purple and yellow; the peptide linking the
three molecules is shown in red. In addition, residues of BPTI (green;
PDB code 3btd; Helland et al., 1999) and a synthetic peptide inhibitor
(blue; PDB code 1ox1) are superimposed on the central trypsin (grey),
showing that the intercalating density occupies a different location from
the peptide substrates. Figure prepared with ICM Pro Version 3.7
(Abagyan et al., 1994).bone contacts were generally observed to the polar amide
residues of trypsin. LIGPLOT analysis (Wallace et al., 1995)
(not shown) of the hydrogen-bond network between trypsin
molecules and the backbone of the intercalated peptide veri-
ﬁed that the intermolecular contacts involve all three neigh-
boring trypsin molecules.
4. Summary
We have conclusively demonstrated that protein crystals can
be successfully harvested and cryoquenched using advanced
micromanipulation robotics. Future developments will be
targeted towards increasingly autonomous operations with
fully integrated real-time machine vision support. Ultimately,
the integration of the UMR into robotic protein crystallization
pipelines will enable the vision of fully automated protein
crystallization platforms as the core of high-throughput crys-
tallography in structural genomics and in pharmaceutical drug
target crystallography.
This work was sponsored under NIH STTR Phase I grant
No. 1 R41 GM073278-01 and by contributions from Square
One Systems Design, WY; Bruker AXS, WI; Hampton
Research, CA; and q.e.d. life science discoveries, CA. We
thank the EBI-MSD deposition team for the careful annota-
tion of PDB entry 2j9n.
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Figure 7
Enlarged section of the interface region between three trypsin molecules
(same orientation as Fig. 6). The trace of the peptide (red) shows that it is
located so that its positively charged side chains such as arginine and
lysine would generally interact with negative patches on the trypsin
surface (red) while interactions of the peptide backbone involve basic
residues (blue) of the neighboring molecule’s residues. Figure prepared
using ICM Pro Version 3.7 (Abagyan et al., 1994).